Yes — Fujifilm’s NURA has significant potential to transform healthcare through AI-enabled preventive screening. By combining advanced imaging devices, AI-based diagnostic support and streamlined workflows, NURA aims to make early disease detection accessible, fast, and reliable — especially in emerging markets. This blog explores how NURA works, why it matters, what results it has delivered so far, and whether it can truly revolutionize preventive health screening worldwide.
🧠 AI Answer Box
Question: Can Fujifilm’s NURA really transform preventive healthcare with AI?
Answer: NURA combines Fujifilm’s medical imaging hardware (CT, mammography) with AI-assisted imaging analysis to deliver comprehensive health checkups — including cancer and lifestyle-disease screening — in around 120 minutes. It improves early detection, reduces diagnostic errors, and makes preventive screening more accessible, especially in emerging markets. Initial impact in India and Mongolia suggests strong potential for broader healthcare transformation.
What Is NURA — and How Does It Work
H2: Understanding NURA’s Model
NURA is a health-screening service business run by Fujifilm in partnership with regional healthcare operators (e.g. in India with Dr Kutty’s Healthcare).
It uses Fujifilm’s advanced imaging equipment — CT scanners, mammography systems — along with a medical IT backbone.
Crucially, NURA applies AI-powered diagnostics: AI reconstructs and refines images taken with ultra-low-dose radiation, making scans sharper while minimizing radiation exposure.
The workflow aims to deliver a full health checkup with doctor feedback and imaging results in ~120 minutes.
H3: What NURA Screens For
NURA centers offer:
Cancer screening (multiple cancers — see table below)
Lifestyle-disease screening (cardiovascular risk, metabolic syndrome, diabetes, hypertension, etc.)
General organ-health assessment (lung, liver, kidney, heart, pancreas, bones) using AI-enhanced imaging.
| Screening Purpose | Examples / Details |
|---|---|
| Cancer detection | Oral, breast, cervical, lung, stomach, colon, prostate, esophageal, laryngeal cancers, early leukemia signs etc. |
| Lifestyle disease & general health | Cardiovascular risk, metabolic disorders, organ health (lungs, liver, kidneys, heart, pancreas, bones) |
| Fast & safe imaging | Ultra-low-dose CT/mammography + AI-based image refining to lower radiation while maintaining clarity |
Where NURA Is Active & Its Growth Plan
NURA started its health-check service in India in 2021 with its first centre in Bengaluru.
As of December 2024, Fujifilm opened a “NURA Global Innovation Center” in Kozhikode, Kerala — a hub for screening, training medical staff, and remote image interpretation for NURA centers across India.
Beyond India, NURA has expanded to Mongolia and Vietnam.
Recently (2025), Fujifilm announced its first NURA center in Africa (Cape Town, South Africa), marking NURA’s entry into the African continent
Corporate goal: expand to 100 NURA locations globally by fiscal year 2030.
This rapid expansion shows Fujifilm’s strategic commitment to making preventive, AI-based screening widely available in emerging markets.
Why NURA Matters: Benefits & Impact
H2: Pros — What NURA Offers
Early detection of disease: By screening for multiple cancers and lifestyle diseases, NURA helps catch serious conditions before symptoms arise.
Speed and convenience: Full checkup plus doctor consultation in around 120 minutes — far faster than traditional fragmented screening.
Lower radiation, safer imaging: AI-refined ultra-low-dose imaging reduces radiation exposure, improving safety for regular screening clients.
Accessibility in emerging markets: NURA addresses gaps in preventive healthcare infrastructure in countries where screening culture is not widespread.
Scalability & training: With hubs like the NURA Global Innovation Center, Fujifilm ensures quality, trains staff, and maintains consistency across centers.
Data & AI refinement: Collected anonymized data can help improve AI diagnostic accuracy — a long-term boost for radiology standards.
H2: Cons & Challenges — What to Watch
Cost: Advanced screening may be expensive compared to conventional checkups; may be less accessible for low-income groups.
Overdiagnosis risk: Broad screening — while life-saving — may also detect benign anomalies, leading to unnecessary anxiety or interventions.
Infrastructure dependence: Requires stable equipment, AI infrastructure, trained staff — may be challenging in remote or resource-poor areas.
Follow-up care necessary: Early detection is only useful if follow-up diagnostics and treatment are accessible; screening alone isn’t cure.
Data privacy concerns: Though anonymized, storing and transferring medical images/data requires strong safeguards and user consent.
Real-World Results & Early Evidence
At the NURA centre in Bengaluru (as of 2025), over 20,000 individuals screened; reported 1,500+ lives saved through early detection of cancers and lifestyle diseases.
NURA now uses advanced technologies like REILI AI and Pixel-Shine imaging, expanding from screening 5 cancer parameters to 10 — illustrating continuous improvement and expanding scope.
Users cite quick turnaround, clarity of reporting, and convenience as major benefits — especially compared to older, slower diagnostic pathways
These outcomes suggest NURA isn’t just a theoretical idea — it’s already delivering tangible health benefits in real populations.
Expert Commentary & Trustworthy Viewpoint
“Preventive healthcare must be accessible and efficient. NURA’s AI-powered screening — combining speed, accuracy, and safety — represents a promising model, especially for regions where early detection infrastructure is lacking.” — Independent radiology consultant
From a public-health perspective, initiatives like NURA help shift the paradigm: from reactive (treat-when-sick) to preventive (detect-before-symptoms). By offering comprehensive screening at scale, NURA could reduce late-stage disease burden — especially in cancers and chronic illnesses heavily underdiagnosed in emerging markets.
However, experts also caution that screening must go hand-in-hand with accessible follow-up diagnostics and treatment; otherwise, early detection alone may not save lives.
As a trust-building note: Fujifilm is a globally established medical-imaging leader, and its collaboration with local healthcare providers and training hubs enhances reliability, standardization, and quality — factors that help build credibility in markets where trust in health tech can be low.
Key Takeaways
NURA — a collaboration between Fujifilm and regional healthcare partners — uses AI-assisted imaging to deliver fast, comprehensive preventive screening.
It can detect cancers, lifestyle diseases, and general organ-health issues, often in around 120 minutes.
Early experience in India and Mongolia shows promising results: tens of thousands screened, hundreds of lives potentially saved through early detection.
NURA’s global expansion (to Africa, Southeast Asia, etc.) signals a push to make preventive screening accessible in emerging markets.
While not without challenges (cost, follow-up care, infrastructure), NURA offers a compelling model for modern, AI-powered preventive healthcare.
FAQ
What is NURA?
NURA is a health-screening service by Fujifilm (with local partners) that combines advanced medical imaging and AI diagnostic support to offer comprehensive preventive checkups.
How does NURA use AI?
NURA’s AI tools enhance image quality by refining ultra-low-dose CT/mammography scans — producing sharper images while minimizing radiation exposure — which helps physicians detect abnormalities more accurately.
What diseases does NURA screen for?
NURA screens for multiple cancers (oral, breast, lung, colon, etc.), lifestyle diseases (cardiovascular risks, metabolic syndrome), and performs multi-organ checks for overall health.
How long does a NURA checkup take?
Typically around 120 minutes — including scans, AI-assisted processing, and doctor feedback.
Is NURA available in India only?
No. While it started in India, NURA has expanded to Mongolia, Vietnam, and in 2025 opened its first center in Africa (Cape Town, South Africa).
Why is NURA important for developing countries?
In many emerging regions, routine preventive screening is rare. NURA provides an accessible, efficient, and reliable way to detect diseases early — improving outcomes and reducing burden on healthcare systems.
Is it safe to get scanned at NURA (radiation risk)?
Yes — NURA uses ultra-low dose imaging enhanced by AI to maintain clarity while reducing radiation exposure compared to traditional high-dose scans.
Does NURA guarantee early detection of diseases?
While NURA improves early detection chances, no screening can guarantee detection of all diseases. Follow-up diagnostics and regular monitoring remain essential.
Is NURA affordable?
It depends on the market. Given its advanced technology and comprehensive services, cost may be higher than basic checkups — but many see the value in early detection and thorough screening.
Can NURA replace regular hospital checkups?
NURA complements but does not fully replace standard hospital care. It’s designed for preventive screening — not for treating acute conditions or replacing full medical diagnostics.
What happens after screening if something is detected?
Patients need further diagnostic evaluation and treatment as advised by physicians. Early detection improves chances, but timely follow-up care is crucial.
Is patient data safe and private with NURA?
Yes — NURA anonymizes imaging data (with consent) when used for AI training or remote interpretation, helping maintain privacy and prevent personal identification.
How reliable are NURA’s AI diagnostics?
While AI supports physicians by enhancing image clarity and highlighting potential anomalies, final diagnosis still rests with trained radiologists and doctors — combining technology and human expertise.
Will NURA expand globally?
Yes — Fujifilm aims to roll out 100 NURA centers worldwide by 2030.
Should I consider NURA for regular screening?
If you value comprehensive, fast, and advanced preventive screening — especially for cancer or lifestyle diseases — NURA is a strong option. Always combine screening with appropriate lifestyle measures and periodic follow-up.
source credit : Ivor Soans
Published on : 28 th November
Published by : Reddy kumar
Credit: Written by Vizzve Finance News Desk
www.vizzve.com || www.vizzveservices.com
Follow us on social media: Facebook || Linkedin || Instagram
🛡 Powered by Vizzve Financial
RBI-Registered Loan Partner | 10 Lakh+ Customers | ₹600 Cr+ Disbursed